Category:
Active Pharmaceutical Ingredients
CAS NO:
--
Standard:
In-house Standards,
Itraconazole Dispersible Tablets
Itraconazole Dispersible Tablets are solid oral dosage forms containing the broad-spectrum antifungal agent itraconazole. Manufactured via wet granulation or direct compression to ensure rapid disintegration, this formulation enhances bioavailability for systemic therapy. The active pharmaceutical ingredient corresponds to the molecular formula C35H38Cl2N4O4 (CAS No. 84625-61-6).
Contraindicated in patients with congestive heart failure or hypersensitivity to triazoles. Requires storage in a cool, dry place below 25°C to maintain stability. Strict adherence to drug-drug interaction protocols is mandatory due to CYP3A4 inhibition risks.